What is Cannprisma?
Cannprisma is a comprehensive Seed-to-Patient solution designed specifically for the medical cannabis industry. It supports every step of the journey—from cultivators and manufacturers to distributors—offering tailored services like raw material sourcing, logistics, manufacturing, packaging, distribution, and regulatory guidance. This all-in-one approach ensures that medical cannabis products meet the highest standards while navigating the complex European market.
Main Benefits of Cannprisma’s Approach
Here’s a quick snapshot of what makes Cannprisma stand out:
- Partnerships with licensed producers worldwide, ensuring raw materials meet strict European quality standards.
- Expertise in global cannabis logistics, including importing, exporting, permits, and safe delivery.
- EU-GMP certified manufacturing facilities that transform raw materials into pharmaceutical-grade APIs with rigorous quality control.
- Secure, tamper-evident packaging solutions that guarantee product safety.
- High production capacity with full traceability under EU-GMP standards.
- Comprehensive regulatory guidance to help clients stay fully compliant with European cannabis laws.
Diverse Sourcing and Quality Control
Cannprisma partners with licensed producers around the globe to source only the highest quality raw materials. These materials are carefully selected to meet the stringent standards required in Europe. On top of that, their EU-GMP certified laboratories provide thorough analytical testing and quality control services. From stability studies to batch release testing, every product is verified to meet pharmaceutical requirements. It’s all about ensuring consistency, safety, and efficacy.
State-of-the-Art Manufacturing and Packaging
The manufacturing process at Cannprisma is nothing short of cutting-edge. Their facilities are equipped to process and transform raw cannabis materials into pharmaceutical-grade active pharmaceutical ingredients (APIs). Quality control is rigorous, and packaging solutions are designed to be secure and tamper-evident, giving peace of mind to both producers and patients. This level of precision and care ensures that every product leaving the facility is top-notch.
Research & Development: Driving Innovation
Innovation is at the heart of Cannprisma’s mission. Their strong Research and Development focus aims to diversify medical cannabis solutions available worldwide. An internal scientific committee collaborates with independent entities and academic institutions to deepen the understanding of cannabis’ medical applications. These partnerships fuel the development of new products and help push the industry forward with scientific rigor and social responsibility.
Project Impact: Sustainable Development Goals (SDGs) Linked to Cannprisma
- Good Health and Well-being (SDG 3): Enhancing patient access to quality medical cannabis products.
- Industry, Innovation, and Infrastructure (SDG 9): Utilizing state-of-the-art manufacturing and R&D.
- Responsible Consumption and Production (SDG 12): Ensuring compliance and sustainable sourcing.
- Partnerships for the Goals (SDG 17): Collaborating with academic and health institutions worldwide.
Cannprisma’s All-Round Solution for Medical Cannabis
What truly sets Cannprisma apart is its multidisciplinary approach—bridging the gap between agriculture and pharmaceuticals. From growing the flower to processing and transforming it into diverse, high-quality cannabis-based medicines, the company operates with scientific rigor and social responsibility. Their Seed-to-Patient model empowers the medical cannabis industry with innovation, compliance, and excellence, ready to elevate operations across the board.
